Introduction: Extractables and Leachables in Lyophilized Drug Products are important pharmaceutical quality considerations because chemical substances originating from packaging and […]
Extractables and Leachables in Lyophilized Drug Products Read More »
Introduction: TTC in Extractables and Leachables (E&L) provides an exposure-based approach for evaluating potential toxicological concerns from low-level chemical substances
Threshold of Toxicological Concern (TTC) in E&L Safety Assessment: A Technical Deep Dive Read More »
Introduction Extractables and Leachables Testing for Peptide Injectables is an essential analytical prerequisite for assessing the chemical compatibility, physical stability,
Introduction: Silicone Lubricant Leachables are chemical substances that can migrate from silicone-lubricated components of a pharmaceutical container or drug-delivery system
Case Study: Silicone Lubricant Leachables in an Auto-Injector Primary Container Read More »
Introduction: Generic injectable manufacturers face a unique quality challenge: unlike oral or topical products, injectables can expose patients directly to
Extractables and Leachables (E&L) Testing for Generic Injectable Drug Products at a CDMO Read More »
Introduction: USP <1663> and <1664> E&L Testing is the analytical backbone that connects a packaging or delivery-system material to a
Introduction Single-Use Systems and GMP Extractables and Leachables (E&L) Testing establishes the analytical foundation necessary for detecting, identifying, quantifying, and
Introduction Designing a GMP-Compliant Extractables and Leachables (E&L) Study requires a structured, risk-based approach that brings together advanced analytical chemistry,
Introduction: Extractable & Leachable Testing for Clinical to Commercial Scale-Up is essential because changes introduced during manufacturing scale-up can alter
Introduction Designing a GMP-Compliant Extractables and Leachables (E&L) Study for container closure systems requires a systematic, risk-tiered analytical framework to
